{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:43:08Z","timestamp":1792204988532,"version":"4.4.0"},"reference-count":21,"publisher":"The Endocrine Society","issue":"8","license":[{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Canadian Institutes of Health Research Project","award":["159533"],"award-info":[{"award-number":["159533"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>False-positive results are common for pheochromocytoma\/paraganglioma (PPGL) real-world screening.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Determine the correlation between screening urine and seated plasma metanephrines in outpatients where PPGL was absent, compared to meticulously prepared and supine-collected plasma metanephrines with age-adjusted references.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Retrospective cohort study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>Databases from a single-provider provincial laboratory (2012-2018), a validated PPGL registry, and a manual chart review from a specialized endocrine testing unit.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Patients<\/jats:title>\n                  <jats:p>PPGL registry data excluded known PPGL cases from the laboratory database. Outpatients having both urine and plasma metanephrines &amp;lt;90 days apart.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The correlation between urine and seated plasma measures along with the total positivity rate. All cases of plasma metanephrines drawn in the endocrine unit were reviewed for test indication and test positivity rate.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>There were 810 non-PPGL pairs of urine and plasma metanephrines in the laboratory database; 46.1% of urine metanephrines were reported high. Of seated outpatient plasma metanephrines drawn a median of 5.9 days later, 19.2% were also high (r\u2005=\u20050.33 and 0.50 for normetanephrine and metanephrine, respectively). In contrast, the meticulously prepared and supine collected patients (n\u2005=\u2005139, 51% prior high urine metanephrines) had &amp;lt;3% rate of abnormal high results in patients without known PPGL\/adrenal mass.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>There was a poor-to-moderate correlation between urine and seated plasma metanephrines. Up to 20% of those with high urine measures also had high seated plasma metanephrines in the absence of PPGL. Properly prepared and collected supine plasma metanephrines had a false-positive rate of &amp;lt;3% in the absence of known PPGL\/adrenal mass.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgab241","type":"journal-article","created":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T05:02:59Z","timestamp":1618290179000},"page":"e2900-e2906","source":"Crossref","is-referenced-by-count":10,"title":["Properly Collected Plasma Metanephrines Excludes PPGL After False-Positive Screening Tests"],"prefix":"10.1210","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8129-9360","authenticated-orcid":false,"given":"Gregory A","family":"Kline","sequence":"first","affiliation":[{"name":"Cumming School of Medicine, Department of Medicine, University of Calgary, Calgary, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Boyd","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology and Laboratory Medicine, University of Calgary, Calgary, Canada"},{"name":"Alberta Precision Laboratories, Calgary, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Polzin","sequence":"additional","affiliation":[{"name":"Alberta Health Services, Calgary, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Harvey","sequence":"additional","affiliation":[{"name":"Cumming School of Medicine, Department of Surgery, University of Calgary, Calgary, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice L","family":"Pasieka","sequence":"additional","affiliation":[{"name":"Cumming School of Medicine, Department of Surgery, University of Calgary, Calgary, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein S M","family":"Sadrzadeh","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology and Laboratory Medicine, University of Calgary, Calgary, Canada"},{"name":"Alberta Precision Laboratories, Calgary, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander A","family":"Leung","sequence":"additional","affiliation":[{"name":"Cumming School of Medicine, Department of Medicine, University of Calgary, Calgary, Canada"},{"name":"Department of Community Health Sciences, University of Calgary, Calgary, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2021,4,13]]},"reference":[{"key":"2021122204332222000_CIT0001","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40200-016-0226-x","article-title":"Does this patient have pheochromocytoma? A systematic review of clinical signs and symptoms","volume":"15","author":"Pourian","year":"2015","journal-title":"J Diabetes Metab Disord."},{"issue":"6","key":"2021122204332222000_CIT0002","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jamcollsurg.2009.09.022","article-title":"Clinical spectrum of pheochromocytoma","volume":"209","author":"Guerrero","year":"2009","journal-title":"J Am Coll Surg."},{"key":"2021122204332222000_CIT0003","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clinbiochem.2020.01.005","article-title":"Very high rate of false positive biochemical results when screening for pheochromocytoma in a large, undifferentiated population with variable indications for testing","volume":"77","author":"Kline","year":"2020","journal-title":"Clin Biochem."},{"issue":"4","key":"2021122204332222000_CIT0004","first-page":"162","article-title":"Diagnostic tests: how to estimate the positive predictive value","volume":"2","author":"Molinaro","year":"2015","journal-title":"Neurooncol Pract."},{"issue":"5","key":"2021122204332222000_CIT0005","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"issue":"15","key":"2021122204332222000_CIT0006","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMra1505550","article-title":"Diagnosis and differential diagnosis of Cushing\u2019s syndrome","volume":"376","author":"Loriaux","year":"2017","journal-title":"N Engl J Med."},{"issue":"6","key":"2021122204332222000_CIT0007","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2021122204332222000_CIT0008","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1210\/jc.2002-030005","article-title":"Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results","volume":"88","author":"Eisenhofer","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2021122204332222000_CIT0009","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/cen.12745","article-title":"Diagnosing phaeochromocytoma\/paraganglioma in a patient presenting with critical illness: biochemistry versus imaging","volume":"83","author":"Amar","year":"2015","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"1","key":"2021122204332222000_CIT0010","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1365-2265.2004.02077.x","article-title":"Does iodine-131 meta-iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial phaeochromocytoma?","volume":"61","author":"Ta\u00efeb","year":"2004","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"11","key":"2021122204332222000_CIT0011","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1373\/clinchem.2018.291369","article-title":"Biochemical diagnosis of chromaffin cell tumors in patients at high and low risk of disease: plasma versus urinary free or deconjugated o-methylated catecholamine metabolites","volume":"64","author":"Eisenhofer","year":"2018","journal-title":"Clin Chem."},{"issue":"3","key":"2021122204332222000_CIT0012","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1530\/EJE-19-0176","article-title":"A high rate of modestly elevated plasma normetanephrine in a population referred for suspected PPGL when measured in a seated position","volume":"181","author":"Boyd","year":"2019","journal-title":"Eur J Endocrinol."},{"issue":"3","key":"2021122204332222000_CIT0013","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1373\/clinchem.2003.024703","article-title":"Measurement of plasma free metanephrine and normetanephrine by liquid chromatography-tandem mass spectrometry for diagnosis of pheochromocytoma","volume":"50","author":"Lagerstedt","year":"2004","journal-title":"Clin Chem."},{"key":"2021122204332222000_CIT0014","doi-asserted-by":"crossref","DOI":"10.1530\/EJE-20-0628","article-title":"Epidemiology of pheochromocytoma and paraganglioma: population-based cohort study","author":"Leung","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"Pt 1","key":"2021122204332222000_CIT0015","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1258\/acb.2012.012066","article-title":"Reference intervals for plasma free metanephrines with an age adjustment for normetanephrine for optimized laboratory testing of phaeochromocytoma","volume":"50","author":"Eisenhofer","year":"2013","journal-title":"Ann Clin Biochem."},{"issue":"6","key":"2021122204332222000_CIT0016","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/jamainternmed.2014.1059","article-title":"Medicine\u2019s uncomfortable relationship with math: calculating positive predictive value","volume":"174","author":"Manrai","year":"2014","journal-title":"JAMA Intern Med."},{"issue":"3","key":"2021122204332222000_CIT0017","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2214\/ajr.158.3.1310825","article-title":"The positive predictive value of mammography","volume":"158","author":"Kopans","year":"1992","journal-title":"AJR Am J Roentgenol."},{"issue":"3","key":"2021122204332222000_CIT0018","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/cen.12624","article-title":"Supine or sitting? The voice of the patient stakeholders: economics vs clinically and medically sound","volume":"82","author":"Sussman","year":"2015","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"4","key":"2021122204332222000_CIT0019","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/cen.12327","article-title":"Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions","volume":"80","author":"D\u00e4rr","year":"2014","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"3","key":"2021122204332222000_CIT0020","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12020-017-1300-y","article-title":"Accuracy of recommended sampling and assay methods for the determination of plasma-free and urinary fractionated metanephrines in the diagnosis of pheochromocytoma and paraganglioma: a systematic review","volume":"56","author":"D\u00e4rr","year":"2017","journal-title":"Endocrine."},{"issue":"10","key":"2021122204332222000_CIT0021","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1515\/cclm-2020-0022","article-title":"Blood sampling for metanephrines comparing venipuncture vs. indwelling intravenous cannula in healthy subjects","volume":"58","author":"Eijkelenkamp","year":"2020","journal-title":"Clin Chem Lab Med."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgab241\/38619607\/dgab241.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/8\/e2900\/41847907\/dgab241.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/8\/e2900\/41847907\/dgab241.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T04:44:37Z","timestamp":1640148277000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/106\/8\/e2900\/6224292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,13]]},"references-count":21,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,4,13]]},"published-print":{"date-parts":[[2021,7,13]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgab241","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,8,1]]},"published":{"date-parts":[[2021,4,13]]}}}